MarketCap
Facebook
X
Telegram
Sientra Cost of Revenue | SIEN
Cost of Revenue is a financial metric that reflects all direct costs associated with the production of goods or the provision of services that directly led to revenue during the reporting period. It is the total amount of expenses incurred by the company to deliver its products or services, including both production costs and related expenses necessary for delivery or customer support.What is included in the cost of revenue
| Cost Category | Examples |
|---|---|
| Production Costs | Materials, wages of production staff, depreciation of equipment |
| Service and Support | Customer service, user support, technical assistance |
| Delivery and Logistics | Packaging, delivery of goods to customers |
| Hosting and Infrastructure | Servers, cloud platforms (especially for IT and SaaS companies) |
| Content and Licenses | License purchases, production royalties (e.g., in streaming services) |
Importance of the Metric
- Helps to understand how costly the revenue-generating process is.
- A high cost of revenue may indicate:
Poor cost control
Low operational efficiency - A low cost of revenue combined with high revenue indicates high profitability and business competitiveness.
Annual Cost of Revenue Sientra
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 49 M | 36.3 M | 23.6 M | 16.4 M | 26.8 M | 14.2 M | 6.88 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 49 M | 6.88 M | 24.7 M |
Quarterly Cost of Revenue Sientra
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9.52 M | 10.5 M | 10.4 M | - | 9.79 M | 8.77 M | 8.55 M | - | 9.03 M | 8.84 M | 10.9 M | - | 8.39 M | 5.55 M | 6.79 M | - | 9.75 M | 7.81 M | 6.47 M | - | 6.4 M | 6.66 M | 6.1 M | - | 3.48 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 10.9 M | 3.48 M | 8.09 M |
Cost of Revenue of other stocks in the Medical devices industry
| Issuer | Cost of Revenue | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AxoGen
AXGN
|
57.9 M | $ 43.32 | 0.04 % | $ 1.99 B |  USA |
 |
Bruker Corporation
BRKR
|
1.86 B | $ 59.67 | 0.18 % | $ 9.06 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
110 M | $ 8.73 | 1.16 % | $ 637 M |  Israel |
 |
ClearPoint Neuro
CLPT
|
14.3 M | $ 14.97 | 13.03 % | $ 424 M | USA |
 |
Conformis
CFMS
|
38.8 M | - | - | $ 16.4 M | USA |
 |
CONMED Corporation
CNMD
|
624 M | $ 45.8 | 3.31 % | $ 1.42 B | USA |
 |
Cytosorbents Corporation
CTSO
|
10.6 M | $ 4.91 | 0.75 % | $ 306 M | USA |
 |
Delcath Systems
DCTH
|
11.8 M | $ 15.96 | 1.8 % | $ 572 M | USA |
 |
Eargo
EAR
|
23 M | - | - | $ 10.2 M | USA |
 |
AdaptHealth Corp.
AHCO
|
2.64 B | $ 5.7 | 0.43 % | $ 770 M | USA |
 |
Electromed
ELMD
|
15.8 M | $ 27.57 | 0.11 % | $ 228 M | USA |
 |
Establishment Labs Holdings
ESTA
|
64.8 M | $ 67.76 | 3.69 % | $ 2.01 B |  Costa-rica |
 |
Edwards Lifesciences Corporation
EW
|
1.33 B | $ 86.82 | 0.51 % | $ 50.8 B | USA |
 |
Align Technology
ALGN
|
1.32 B | $ 148.17 | 4.36 % | $ 10.7 B | USA |
 |
Helius Medical Technologies
HSDT
|
500 K | $ 2.88 | 2.45 % | $ 63.5 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
804 M | $ 15.53 | 2.76 % | $ 1.19 B | USA |
 |
Inogen
INGN
|
194 M | $ 5.09 | 2.55 % | $ 135 M | USA |
 |
Inspire Medical Systems
INSP
|
133 M | $ 69.06 | 0.57 % | $ 2.03 B | USA |
 |
IRIDEX Corporation
IRIX
|
33.4 M | $ 0.63 | 0.08 % | $ 10.7 M | USA |
 |
IRadimed Corporation
IRMD
|
19.5 M | $ 86.35 | 0.08 % | $ 1.1 B | USA |
 |
Integer Holdings Corporation
ITGR
|
1.35 B | $ 126.32 | 0.02 % | $ 4.39 B | USA |
|
LENSAR
LNSR
|
31.3 M | $ 7.15 | 0.14 % | $ 85.5 M | USA |
 |
Apyx Medical Corporation
APYX
|
19.8 M | $ 2.95 | 1.37 % | $ 121 M | USA |
 |
Cutera
CUTR
|
171 M | - | -10.19 % | $ 1.99 M | USA |
 |
Medtronic PLC
MDT
|
12.7 B | $ 89.3 | 0.08 % | $ 114 B | USA |
 |
MiMedx Group
MDXG
|
73 M | $ 4.77 | 0.2 % | $ 705 M | USA |
 |
Accuray Incorporated
ARAY
|
290 M | $ 0.23 | 1.0 % | $ 28.2 M | USA |
 |
Myomo
MYO
|
14 M | $ 1.64 | 0.3 % | $ 68.6 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
25.8 M | $ 0.7 | 0.45 % | $ 45.4 M | Israel |
 |
Nemaura Medical
NMRD
|
75.3 K | - | -17.8 % | $ 2.74 M |  Britain |
 |
InspireMD
NSPR
|
6.33 M | $ 0.74 | 0.16 % | $ 47.6 M | Israel |
 |
Orthofix Medical
OFIX
|
256 M | $ 9.18 | 2.23 % | $ 364 M |  Curacao |
 |
Outset Medical
OM
|
72.7 M | $ 3.09 | 5.45 % | $ 47 K | USA |
 |
Boston Scientific Corporation
BSX
|
6.22 B | $ 44.62 | 0.31 % | $ 66.1 B | USA |
 |
Insulet Corporation
PODD
|
768 M | $ 136.49 | 0.01 % | $ 9.6 B | USA |
 |
Profound Medical Corp.
PROF
|
4.7 M | $ 5.74 | 0.16 % | $ 174 M |  Canada |
 |
Quanterix Corporation
QTRX
|
73.9 M | $ 3.16 | 4.93 % | $ 135 M | USA |
 |
AVITA Medical
RCEL
|
12.8 M | $ 10.95 | 0.61 % | $ 305 M |  Australia |
 |
Neovasc
NVCN
|
556 K | - | - | $ 111 M | Canada |
 |
Sintx Technologies
SINT
|
557 K | $ 1.78 | 3.98 % | $ 4.94 M | USA |
 |
Smith & Nephew plc
SNN
|
1.97 B | $ 26.82 | 0.07 % | $ 23.3 B | Britain |
 |
Inari Medical
NARI
|
59.1 M | - | - | $ 4.23 B | USA |
 |
Sensus Healthcare
SRTS
|
15.6 M | $ 3.03 | 0.32 % | $ 49.5 M | USA |
 |
Stryker Corporation
SYK
|
9.05 B | $ 273.4 | 0.38 % | $ 104 B | USA |
 |
Tactile Systems Technology
TCMD
|
79.4 M | $ 22.43 | 0.55 % | $ 513 M | USA |
 |
TELA Bio
TELA
|
25.6 M | $ 1.3 | 0.71 % | $ 61 M | USA |
 |
Viemed Healthcare
VMD
|
115 M | $ 8.8 | 1.24 % | $ 342 M | USA |
 |
Varex Imaging Corporation
VREX
|
554 M | $ 18.45 | 0.05 % | $ 764 M | USA |